| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 2 | +100.00% | -10.50% | +0.49% | -10.99% | -10.99% | — |
| 14d | 2 | +0.00% | +42.78% | +0.24% | +42.54% | +42.54% | — |
| 30d | 2 | +0.00% | +25.43% | -1.97% | +27.40% | +27.40% | — |
| 60d | 2 | +50.00% | +9.42% | -10.46% | +19.88% | +19.88% | — |
| 90d | 2 | +50.00% | +8.93% | -1.10% | +10.03% | +10.03% | — |
| 180d | 2(1 pending) | +100.00% | -35.33% | +4.32% | -39.65% | -39.65% | — |
| 1y | 2(1 pending) | +0.00% | +4.19% | +15.70% | -11.51% | -11.51% | — |
| 2y | 2(2 pending) | — | — | — | — | — | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 539,072 | — | — | 539,072 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE SVP, General Counsel | 22,900 | $1.76 | $40.3K | 564,948 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 152,480 | — | — | 152,480 | Feb 2, 2026 | Feb 4, 2026 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE SVP, General Counsel | 6,404 | $1.71 | $11.0K | 587,848 | Feb 3, 2025 | Feb 5, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 512,370 | — | — | 512,370 | Jan 24, 2025 | Jan 28, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 144,928 | — | — | 594,252 | Jan 24, 2025 | Jan 28, 2025 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | SALE SVP, General Counsel | 28,310 | $2.79 | $78.8K | 449,324 | Aug 21, 2024 | Aug 23, 2024 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 41,800 | — | — | 477,634 | Jan 25, 2024 | Jan 31, 2024 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 147,778 | — | — | 147,778 | Jan 25, 2024 | Jan 31, 2024 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 960,854 | — | — | 960,854 | Aug 14, 2023 | Aug 17, 2023 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 326,876 | — | — | 435,834 | Aug 14, 2023 | Aug 17, 2023 ↗ | View → |
| ALLO ALLOGENE THERAPEUTICS, INC. | PURCHASEGRANT Stock grant | 108,958 | — | — | 108,958 | Aug 14, 2023 | Aug 17, 2023 ↗ | View → |